Markets:

Overview

News

Currencies

International

Treasuries

Anebulo Pharmaceuticals, Inc. - Common Stock (NQ:ANEB)

1.130 +0.120 (+11.88%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Anebulo Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More ↗

June 23, 2022

Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 14, 2022

Via Benzinga

The Risks of Cannabis Over-Consumption ↗

October 05, 2021

Photo by Olga Ko...

Via Benzinga

Topics Cannabis

CB1 Antagonists as a Solution to the Complicated Problems of Cannabis Over-intoxication ↗

September 13, 2021

The legalization of recreational cannabis in a number of states is associated with the increasing problem of acute cannabis intoxication (ACI).

Via Benzinga

Topics Cannabis

95 Biggest Movers From Yesterday ↗

June 07, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

May 27, 2022

During Friday's session, 59 stocks hit new 52-week lows.

Via Benzinga

Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer

May 24, 2022

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2022 Financial Results and Recent Updates

May 11, 2022

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

53 Biggest Movers From Yesterday ↗

April 21, 2022

Gainers ION Geophysical Corporation (NYSE: IO) shares surged 91.2% to settle at $0.6980 on Wednesday. ION Geophysical was awarded a five-year contract by Brunei Shell Petroleum...

Via Benzinga

Anebulo Pharmaceuticals Doses More Than Half of the Subjects in Part A of a Phase 2 Clinical Trial and Provides Guidance on IND Submission

April 01, 2022

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 14, 2022

Gainers Incannex Healthcare (NASDAQ:IXHL) stock moved upwards by 48.0% to $20.95 during Monday's regular session. The company's market cap stands at $1.0 billion....

Via Benzinga

The Week In Cannabis: Schumer's Bill, The Super Bowl, Leafly, Canopy Growth, Tilray, Hexo, Sundial And More ↗

February 11, 2022

Below is a recap of the main news related to the cannabis industry and markets for the week of February 7, 2022. Contents

Via Benzinga

Anebulo Pharmaceuticals Reports Q2 Financial Results, Plans To Develop Therapy For Acute Cannabinoid Intoxication ↗

February 11, 2022

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) announced financial results for the three months ended December 31, 2021 and recent updates.

Via Benzinga

Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2022 Financial Results and Recent Updates

February 11, 2022

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference

January 06, 2022

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals Appoints Scott L. Anderson as Head of Investor Relations and Public Relations

January 06, 2022

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director

January 04, 2022

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals Announces Initiation of Phase 2 Clinical Study Evaluating ANEB-001 for the Treatment of Acute Cannabinoid Intoxication

January 03, 2022

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2022 Financial Results and Provides a Business Update

November 12, 2021

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 29, 2021

Gainers MiNK Therapeutics (NASDAQ:INKT) shares rose 16.88% to $16.96 during Friday's regular session. Vocera Communications (NYSE:VCRA) shares increased by 12.13% to $...

Via Benzinga

Anebulo Pharmaceuticals Announces Issuance of U.S. Patent Covering Use of ANEB-001 for the Treatment of Acute Cannabinoid Overdose

October 13, 2021

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Overdose Unknown: How Anebulo Pharmaceuticals Is Working to Solve a Growing Marijuana Overdose Problem ↗

October 12, 2021

Photo by Elsa Olofsson

Via Benzinga

Topics Cannabis

Anebulo Pharmaceuticals to Participate in the Benzinga Cannabis Capital Conference in New York City

October 05, 2021

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

The Unintended Consequences of Ever-Increasing Marijuana Potency ↗

September 27, 2021

Photo by Tim Foster...

Via Benzinga

Topics Cannabis

CBD-Focused Anebulo Pharma Posts Q4 & Full Year 2021 Earnings, Launching Phase 2 Cannabis Overdose Clinical Trials ↗

September 23, 2021

Cannabinoid-focused biotech company Anebulo Pharmaceuticals, Inc. (NASDAQ:

Via Benzinga

Topics Cannabis

Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides a Business Update

September 22, 2021

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Cannabis Edibles are Leading to More Negative Outcomes in Cannabis Users ↗

September 20, 2021

Photo by camilo jimenez on...

Via Benzinga

Topics Cannabis

Anebulo Pharmaceuticals Announces Completion of Manufacturing of ANEB-001 Capsules for Upcoming Phase 2 Clinical Trial

September 13, 2021

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 07, 2021

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo is Developing an Antidote to Cannabis Intoxication ↗

September 07, 2021

The company Anebulo Pharmaceuticals (NASDAQ: ANEB) is investing in an antidote for cannabis intoxication. The social and medical issues associated with acute cannabis intoxication...

Via Benzinga

Topics Cannabis

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.